Clinical Trial Results:
A multinational multicentre randomised paralle group study on therapeutic efficacy and tolerability of PIASCLEDINE capsules 300 mg in comparison with placebo in the treatment of hip osteoarthritis
Summary
|
|
EudraCT number |
2004-000979-33 |
Trial protocol |
IT |
Global completion date |
29 Nov 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jul 2022
|
First version publication date |
02 Jul 2022
|
Other versions |
|
Summary report(s) |
ITAES PR 2503 OUTLINES 1 - PR2503 ITAES CLINICAL Report 1 - PR2503 ITAES CSR ADDENDUM SAFETY VF |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.